Diabetes Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Diabetes stocks.

Diabetes Stocks Recent News

Date Stock Title
May 29 NBIX Neurocrine Biosciences to Participate at Investor Conferences in June
May 29 ZURA Zura Bio Announces Participation in June Investor Conferences
May 28 IONS Ionis: Tough Run For Share Price Belies Multiple Reasons For Optimism
May 28 NBIX Neurocrine Biosciences CEO Gorman stepping down in October
May 28 NBIX Neurocrine Biosciences Announces CEO Succession Plan
May 28 NBIX Neurocrine Biosciences to Present New Phase 3 CAHtalystâ„¢ Data in Adult and Pediatric Patients with CAH and Study Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH at ENDO 2024
May 28 VTVT CANTEX PHARMACEUTICALS ANNOUNCES FOUR ABSTRACTS TO BE PRESENTED FEATURING AZELIRAGON AT 2024 ASCO ANNUAL MEETING
May 28 IONS Ionis to hold donidalorsen Phase 3 data webcast
May 28 PODD Insulet to Present at the Jefferies Global Healthcare Conference
May 27 VTVT Shareholders in vTv Therapeutics (NASDAQ:VTVT) are in the red if they invested three years ago
May 24 ZURA Zura Bio files to sell 41.6M Class A ordinary shares for holders
May 24 IONS The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar Therapeutics
May 23 PODD Here's Why Insulet (PODD) is a Strong Momentum Stock
May 23 OTRK Ontrak Launches Groundbreaking Mental Health Digital Twin Technology, Revolutionizing Precision Mental Healthcare Delivery
May 23 IONS New data from the Phase 3 NEURO-TTRansform study evaluating WAINUAâ„¢ (eplontersen) to be presented at the 2024 International Symposium on Amyloidosis (ISA)
Diabetes

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags